VeriMomursoloyl tetrapeptide-37 est-il sûr pendant la grossesse ?
No harmonised CLP classification, SCCS opinion, or CIR safety assessment was identified for ursoloyl tetrapeptide-37 and no peer‑reviewed reproductive toxicity studies were found indicating developmental or reproductive hazard. Mechanistic reproductive concerns (endocrine disruption, retinoid‑like activity, etc.) were not identified. Dermal exposure from cosmetics is likely low but measurable for a small peptide/triterpenoid conjugate, so exposure score is 1. (Sources searched: ECHA Annex VI/C&L, SCCS/CIR, PubMed, ECHA dossiers, PubChem, CosIng, EWG.)
Related ingredients
Frequently asked questions
- ursoloyl tetrapeptide-37 est-il sûr pendant la grossesse ?
- No harmonised CLP classification, SCCS opinion, or CIR safety assessment was identified for ursoloyl tetrapeptide-37 and no peer‑reviewed reproductive toxicity studies were found indicating developmental or reproductive hazard. Mechanistic reproductive concerns (endocrine disruption, retinoid‑like activity, etc.) were not identified. Dermal exposure from cosmetics is likely low but measurable for a small peptide/triterpenoid conjugate, so exposure score is 1. (Sources searched: ECHA Annex VI/C&L, SCCS/CIR, PubMed, ECHA dossiers, PubChem, CosIng, EWG.)
- ursoloyl tetrapeptide-37 est-il sûr pendant l'allaitement ?
- No data indicating lactation/breast‑milk transfer or adverse effects in nursing infants. No mechanistic data suggesting accumulation in milk. Dermal exposure from cosmetics is likely low but measurable, so exposure scored 1.
- ursoloyl tetrapeptide-37 est-il sûr pour la peau de bébé ?
- No infant‑specific toxicity data were identified. Given measurable dermal absorption in adults (scored 1) and the higher surface‑area‑to‑weight and immature barrier in infants 0–3 y, exposure is increased by +1 per instructions to e=2. No evidence was found to increase hazard or mechanism scores for infants.
- Comment VeriMom évalue-t-il ursoloyl tetrapeptide-37 ?
- VeriMom évalue ursoloyl tetrapeptide-37 à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à ursoloyl tetrapeptide-37 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à ursoloyl tetrapeptide-37 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.